All Companies

STECongressional Stock Trades

STERIS plc

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Congressional stock trades in STERIS plc (STE) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

12

Politicians Trading

4

Last Traded

Aug 25, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
April McClain DelaneyDSep 9, 2026Aug 25, 2026Sell$100,001 - $250,000-13.28%
Jared MoskowitzDAug 27, 2026Jul 13, 2026Sell$1,001 - $15,000-5.53%
April McClain DelaneyDAug 3, 2026Jul 31, 2026Sell$1,001 - $15,000-10.23%
April McClain DelaneyDAug 3, 2026Jul 29, 2026Sell$1,001 - $15,000-12.69%
April McClain DelaneyDAug 3, 2026Jul 27, 2026Sell$1,001 - $15,000-6.12%
April McClain DelaneyDAug 3, 2026Jul 24, 2026Sell$1,001 - $15,000-4.22%
April McClain DelaneyDMar 10, 2026Feb 6, 2026Buy$1,001 - $15,000-18.69%
Gilbert Ray Cisneros, Jr.DMar 9, 2026Feb 10, 2026Buy$1,001 - $15,000-16.20%
April McClain DelaneyDOct 6, 2025Sep 18, 2025Buy$1,001 - $15,000-18.15%
April McClain DelaneyDOct 6, 2025Sep 11, 2025Buy$1,001 - $15,000-18.77%
April McClain DelaneyDJul 2, 2025Jun 26, 2025Sell$1,001 - $15,000-14.04%

Price History

About STERIS plc

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.